Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
VoIP-Pal Affirms Court Acceptance of Second Amended Complaint and Service upon Defendants in Federal Antitrust and RICO Lawsuit
-
Loadsmart Announces Brokerage and Managed Transportation Leader Geoff Kelley as New COO
-
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
-
IES Holdings Appoints Kelly C. Janzen to its Board of Directors
-
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters
-
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist
-
GIA GemKit Brings Gem Science to Any Classroom
-
Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials
-
Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results
-
ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
-
StorONE’s NVMe Technology Chosen to Power Leading Credit Company’s Storage Needs
-
Liberty Defense has Appointed The Honorable David Kris, Former Assistant Attorney General for National Security and Deputy General Counsel and Chief Compliance Officer at Time Warner, Inc. and Founder
-
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
-
Microchip Opens Registration for its 25th Annual MASTERs Conference in Scottsdale, Arizona
-
Protara Therapeutics to Participate in Upcoming Investor Conferences
-
Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway
-
DJI Mavic 4 Pro Spins Up a Game-Changing Drone with the Mavic 4 Pro; Learn More Info at B&H
-
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
-
Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
-
Highwire Appoints Powerhouse Michael O’Brien as CEO
-
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results
-
Viasat Selected by U.S. Space Force for Phase 2 of Enterprise Space Terminal Program
-
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
-
GrowGeneration’s MMI Announces New Luxury Mobile Package & Luggage Storage Solution Designed Exclusively for Waldorf Astoria Hotels
-
Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
-
Silicon Motion to Attend Upcoming Investor Conferences
-
Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems
-
Reviva to Participate in the A.G.P. Healthcare Company Showcase
-
Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic Innovation
-
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
-
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025
-
DJI Mavic 4 Pro Spins Up a Game-Changing Drone with the Mavic 4 Pro; Learn More Info at B&H
-
Apollo Hybrid Funds to Acquire PowerGrid Services from The Sterling Group
-
UPCX Becomes Official Associate Partner of Formula E Tokyo E-Prix 2025, Advancing Web3 and Sustainable Mobility
-
Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies
-
GrowGeneration’s MMI Announces New Luxury Mobile Package & Luggage Storage Solution Designed Exclusively for Waldorf Astoria Hotels
-
MicroAlgo Inc. Develops Blockchain-Based Traceable IP Rights Protection Algorithm
-
Chanson International’s “Songkang Meal” Nasogastric Nutrition Formula Approved for Use in China
-
Verizon to speak at MoffettNathanson conference May 15
-
Mindera Health™ announces publication of randomized, prospective clinical utility study demonstrating improved psoriasis patient outcomes
-
MeiraGTx Reports First Quarter 2025 Financial and Operational Results
-
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
-
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22
-
Pulse Oil Corp. Announces Suspension of Trading
-
Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems
-
NEVGOLD ADDS MORE SIGNIFICANT OXIDE GOLD-ANTIMONY RESULTS: 2.19 G/T AUEQ OVER 64.0 METERS (0.72 G/T AU AND 0.33% ANTIMONY), INCLUDING 4.17 G/T AUEQ OVER 24.1 METERS (1.47 G/T AU AND 0.60% ANTIMONY),
-
Acronis Ecosystem Reaches 300 Technology Integrations, Drives New Opportunities for MSPs and ISVs
-
CareCloud Named “Top Healthcare IT Pick for 2025” by Maxim Group; AI Initiative Recognized as Key Growth Driver
-
Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments
-
Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference

